Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced the lodgement of an international patent application aimed at protecting the use of Veyonda (idronoxil) in blocking the development of septic shock associated with infections. …
New data moves Noxopharm to protect Veyonda in septic shock treatment
April 6, 2021 Australian Biotech
Latest Video
New Stories
-
PSDs are not an 'obligation' under trade agreement
April 9, 2021 - - Latest News -
More risk for government this time around in agreement negotiation
April 9, 2021 - - Latest News -
This change will not enhance transparency of decision-making
April 9, 2021 - - Latest News -
Daily updates on COVID-19 vaccine - 9 April 2021
April 9, 2021 - - COVID-19 -
Government scraps October timeline after accepting ATAGI advice
April 9, 2021 - - Latest News -
More come forward to question move on confidentiality protections
April 9, 2021 - - Latest News -
Guild's Trent Twomey on costs and the access challenge
April 8, 2021 - - Latest News